(Q48405212)

11 February 2018

title

A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors (English)

1 reference

11 February 2018

main subject

phase II clinical trial

0 references

author name string

C A Arndt

1

1 reference

11 February 2018

M D Krailo

2

1 reference

11 February 2018

L Steinherz

3

1 reference

11 February 2018

B Scheithauer

4

1 reference

11 February 2018

W Liu-Mares

5

1 reference

11 February 2018

G H Reaman

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

11 February 2018

published in

Cancer

1 reference

11 February 2018

volume

83

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

813-816

1 reference

11 February 2018

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Designs for group sequential phase II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980815%2983%3A4%3C813%3A%3AAID-CNCR27%3E3.0.CO%3B2-U

10.1002/(SICI)1097-0142(19980815)83:4<813::AID-CNCR27>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018